# ED90 of Teglidine for Suppressing LMA Insertion Response in the Elderly

> **NCT07096115** · NA · NOT_YET_RECRUITING · sponsor: **The First People's Hospital of Lianyungang** · enrollment: 45 (estimated)

## Conditions studied

- Urological Surgery

## Interventions

- **DRUG:** Taiglididine

## Key facts

- **NCT ID:** NCT07096115
- **Lead sponsor:** The First People's Hospital of Lianyungang
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-06-30
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07096115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07096115, "ED90 of Teglidine for Suppressing LMA Insertion Response in the Elderly". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07096115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
